Your browser doesn't support javascript.
loading
Comparison of cell-free and small extracellular-vesicle-associated DNA by sequencing plasma of lung cancer patients.
Moldovan, Norbert; Verkuijlen, Sandra; van der Pol, Ymke; Bosch, Leontien; van Weering, Jan R T; Bahce, Idris; Pegtel, D Michiel; Mouliere, Florent.
Afiliação
  • Moldovan N; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Verkuijlen S; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • van der Pol Y; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Bosch L; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • van Weering JRT; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Human Genetics and Functional Genomics, Center for Neurogenomics and Cognitive Research, 1081 HV Amsterdam, the Netherlands.
  • Bahce I; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pulmonology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Pegtel DM; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.
  • Mouliere F; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Center Amsterdam, 1081 HV Amsterdam, the Netherlands.
iScience ; 27(9): 110742, 2024 Sep 20.
Article em En | MEDLINE | ID: mdl-39262778
ABSTRACT
Blood contains multiple analytes that can be used as liquid biopsy to analyze cancer. Mutations have been detected in DNA associated with small extracellular vesicles (sEVs). The genome-wide composition and structure of sEV DNA remains poorly characterized, and whether sEVs are enriched in tumor signal compared to cell-free DNA (cfDNA) is unclear. Here, using whole-genome sequencing from lung cancer patients we determined that the tumor fraction and heterogeneity are comparable between DNA associated with sEV (<200 nm) and matched plasma cfDNA. sEV DNA, obtained with size-exclusion chromatography, is composed of short ∼150-180 bp fragments and long >1000 bp fragments poor in tumor signal. The structural patterns of sEV DNA are related to plasma cfDNA. Mitochondrial DNA is relatively enriched in the sEV fractions. Our results suggest that DNA associated to sEV (including exosomes) is not preferentially enriched in tumor signal and is less abundant than cfDNA.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article